ARTICLE | Distillery Therapeutics
Inhibiting IL-33-driven inflammation to treat brain cancer
October 28, 2020 8:15 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Brain cancer...
BCIQ Company Profiles
BCIQ Target Profiles
DISEASE CATEGORY: Cancer
INDICATION: Brain cancer...
BCIQ Company Profiles
BCIQ Target Profiles